In our last virtual panel discussion, the audience identified better process understanding and knowledge transfer between units as key drivers to speed up the bioprocess development in the future.
But how does this impact the technology transfer from lab to industrial scale? How can we profit from QbD, process understanding and knowledge transfer during tech transfers and speed up time to market?
Would you like to discuss these and more questions with our experts and share your opinion? Then join Ron Bates (Immunovant), Pieter Jacobs (UCB), Rene Labatut (Sanofi), Pieter Jacobs (UCB), and Roland Maichin (ZETA) for the 3rd session of this free virtual panel discussion:
The Future of Bioprocess Development –
Fast-Track: Tech Transfer from Lab to Industrial Scale
Date: 27.01.2021 // Time: 4-5 p.m. (UTC+1)
Hosted by: Julita Panek (SIEMENS), Mark Dürkop (NOVASIGN) and Martin Mayer (ZETA)
We look forward to your participation and to an exciting discussion.